Showing results (51-60 of 240) with videos related to
Sort By:
Pageof 24
Journal of Neurosurgery|March 1, 1983
In vivo characterization of vasocontractile activities in erythrocytesM P McIlhany, L M Johns, T Leipzig, et al.Journal of Computer Assisted Tomography|May 1, 1997
Orbital involvement in Wegener granulomatosis: MR findings in 12 patientsN A Courcoutsakis, C A Langford, M C Sneller, et al.Radiology|March 1, 1995
von Hippel-Lindau disease: genetic, clinical, and imaging featuresP L Choyke, G M Glenn, M M Walther, et al.The Journal of Rheumatology|January 1, 1990
Acute transverse myelitis in systemic lupus erythematosus: magnetic resonance imaging and review of the literatureD T Boumpas, N J Patronas, M C Dalakas, et al.AJNR. American Journal of Neuroradiology|May 1, 1983
Glycolytic rate (PET) and contrast enhancement (CT) in human cerebral gliomasN J Patronas, R A Brooks, R L DeLaPaz, et al.Journal of Clinical Neuro-Ophthalmology|June 1, 1987
Glucose utilization of visual cortex following extra-occipital interruptions of the visual pathways by tumor. A positron emission tomography studyD S Fishbein, G A Chrousos, G Di Chiro, et al.Neurosurgery|January 1, 1989
Positron emission tomography in the detection of malignant degeneration of low-grade gliomasT L Francavilla, R S Miletich, G Di Chiro, et al.Journal of Neurosurgery|June 1, 1985
Prediction of survival in glioma patients by means of positron emission tomographyN J Patronas, G Di Chiro, C Kufta, et al.Annals of Neurology|December 1, 1984
Cortical abnormalities in Alzheimer's diseaseN L Foster, T N Chase, L Mansi, et al.Acta Radiologica. Supplementum|January 1, 1990
Metalloporphyrin magnetic resonance contrast agents. Feasibility of tumor-specific magnetic resonance imagingP C van Zijl, D A Place, J S Cohen, et al.Pageof 24